IMCR
Immunocore Holdings Ltd
30.50$
-3.7%
vs. previous close
Closing price · As of: Nov 12, 2026
Statements
Income Statement
Immunocore Holdings Ltd (IMCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 400 million GBP. Tick rows to compare them in a chart.
All figures in millions of GBP.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.4 | 11 | 16 | 14 | 24 | 26 | 30 | 27 | 144 | 197 | 310 | 400 | |
| – | – | – | – | – | 100 | 75 | 74 | 5.3 | 0.8 | 6.9 | 8.4 | |
| 6.4 | 11 | 16 | 14 | 24 | -74 | -45 | 27 | 139 | 197 | 304 | 392 | |
| 12 | 22 | 46 | 61 | 84 | 100 | 75 | 74 | 84 | 129 | 222 | 275 | |
| 2.5 | 3.0 | 3.7 | 22 | 34 | 44 | 46 | 119 | 94 | 155 | 156 | 165 | |
| 14 | 25 | 49 | 83 | 118 | 44 | 41 | 156 | 182 | 244 | 374 | 437 | |
| -7.3 | -14 | -32 | -68 | -93 | -118 | -86 | -129 | -43 | -47 | -70 | -45 | |
| – | – | 0.0 | 0.0 | 0.8 | 3.8 | 3.1 | 5.6 | 5.4 | 4.1 | 24 | 16 | |
| -7.2 | 14 | -31 | -65 | -88 | -82 | -87 | -133 | -34 | -48 | -53 | -19 | |
| 1.6 | 1.0 | 8.1 | 16 | -17 | 22 | -13 | 0.1 | 9.6 | -4.4 | -1.9 | 16 | |
| -5.6 | 13 | -23 | -50 | -72 | -104 | -74 | -133 | -43 | -44 | -51 | -36 | |
| -6.6 | -11 | -30 | -64 | -87 | -109 | -80 | -124 | -38 | -41 | -47 | 0.5 |
Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.